drug
memantine hydrochloride
Marketedupdated 5mo agoby Polygen Pharmaceuticals Inc
Approvedcommunity read0 votes
indications
investigational
Alzheimer's Disease
all catalysts(0)
nothing on the calendar yet
Trials studying memantine hydrochloride
Patent cliff
source: FDA Orange Bookfirst barrier falls
Mar 24, 2029
~2.5 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (8)
- Sep 24, 2029patentUS 8039009*PED3.0y
- Sep 24, 2029patentUS 8039009*PED3.0y
- Sep 24, 2029patentUS 8039009*PED3.0y
- Sep 24, 2029patentUS 8039009*PED3.0y
- Mar 24, 2029method-of-use (U-539)US 80390092.5y
- Mar 24, 2029method-of-use (U-539)US 80390092.5y
- Mar 24, 2029method-of-use (U-539)US 80390092.5y
- Mar 24, 2029method-of-use (U-539)US 80390092.5y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 5h ago
Found something off?
comments(0)
5-min edit window · permanent after that